Related Experiment Video
Updated: Jul 12, 2025

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
Airway Involvement and Intervention in Non-ACE-Inhibitor-Induced Angioedema
Bartholomew J Bacak1, Michael S Castle1, Chantal Barbot2
1Department of Otolaryngology - Head and Neck Surgery, University of Rochester Medical Center, Rochester, New York, U.S.A.
Non-angiotensin-converting enzyme inhibitor (ACEI)-induced angioedema requires prompt assessment. Key indicators for airway intervention include dysphonia, specific blood pressure readings, and the extent of airway swelling.
Area of Science:
- Emergency Medicine
- Otolaryngology
- Critical Care
Background:
- Angioedema, particularly non-ACEI-induced, presents a diagnostic challenge in emergency settings.
- Identifying patients at risk for airway compromise is crucial for timely intervention.
Purpose of the Study:
- To characterize patients with non-ACEI-induced angioedema.
- To identify risk factors predicting the need for airway intervention.
Main Methods:
- Retrospective review of 181 adult patients with non-ACEI-induced angioedema over 4.5 years.
- Flexible laryngoscopy was used for evaluation; data included demographics, vitals, symptoms, and edema location.
- Statistical analysis identified factors associated with airway intervention.
Main Results:
- 11 patients (6.1%) required airway intervention (intubation).
- Significant predictors for airway intervention included dysphonia, diastolic blood pressure, mean arterial pressure, and the presence/number of edematous airway sites.
- Demographics, prior angioedema history, and ED treatments did not correlate with airway intervention.
Conclusions:
- Dysphonia, specific blood pressure parameters (DBP, MAP), and the anatomical extent of edema are key indicators for airway intervention in non-ACEI-induced angioedema.
- These findings aid in risk stratification and management decisions for patients presenting with this condition.
Related Concept Videos
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Direct Renin Inhibitors
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Cardiopulmonary Resuscitation II: ACLS Airway Management
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Antihypertensive Drugs: Angiotensin II Receptor Blockers

